ClinicalTrials.Veeva

Menu

Preemptive Versus Preventive Antiemetic Treatment

N

National and Kapodistrian University of Athens

Status

Unknown

Conditions

Postoperative Nausea and Vomiting

Treatments

Other: Antiemetics perioperatively

Study type

Interventional

Funder types

Other

Identifiers

NCT03023306
IRB No 65/19-06-18

Details and patient eligibility

About

Patients aged between 20 and 70 years, ASA physical status I-III, and scheduled for laparoscopic cholecystectomy under general anaesthesia will be enrolled in the study.

Patients will be randomized to the preemptive group to receive an antiemetic regime 1h before the start of surgery or to the intraoperative group to receive the same antiemetic drugs in the same doses intraoperatively, 30 min before the end of surgery.

In the operating room standard monitoring and a standardized anesthetic technique will be implemented in all patients. Nausea, vomiting, retching and PONV (cumulative) will be recorded at PACU, at 4h, 8h and 24h postoperatively. Pain scores assessed by NRS (numerical rating scale) will be recorded at the same time points. Also, when patients received fluids and solid food by mouth will be recorded.

Enrollment

115 estimated patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA physical status I-III patients
  • Surgical procedure: scheduled for laparoscopic cholecystectomy
  • Type of anesthesia: general

Exclusion criteria

  • Antihistamines the last three days
  • Antiemetic drugs the last three days
  • Hiatus hernia
  • reflux
  • Gastrointestinal disease
  • Pregnancy
  • BMI > 35
  • parkinson
  • known allergy to the drugs of the protocol
  • epilepsy

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

115 participants in 2 patient groups

preemptive group
Active Comparator group
Description:
The preemptive group will receive the anti-emetic regimen i.v. (4 mg of ondansetron) 1h before the start of surgery. During surgery, 30 min before the end of operation, this group will receive i.v. 0.9% NaCl in equal volumes.The intervention consists of the different time points of antiemetic treatment, thus 1h before surgery vs intraopertively. Intervention: Antiemetic treatment 1h before surgery
Treatment:
Other: Antiemetics perioperatively
intraoperative group
Other group
Description:
The preventive group will receive i.v. 0.9% NaCl 1h before surgery and ondansetron 4 mg 30 min before the end of surgery at equal volumes. Intervention: Antiemetic treatment intraoperatively
Treatment:
Other: Antiemetics perioperatively

Trial contacts and locations

1

Loading...

Central trial contact

Chryssoula Staikou, MD, PhD, DESA; Argyro Fassoulaki, MD PhD DEAA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems